Skip to main content

Advertisement

SpringerLink
Log in

Plasma BDNF levels are correlated with aggressiveness in patients with amnestic mild cognitive impairment or Alzheimer disease

  • Neurology and Preclinical Neurological Studies - Original Article
  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Abstract

In the present study, we examined whether neuropsychiatric symptoms were correlated with plasma brain-derived neurotrophic factor (BDNF) levels as a state marker or were associated with the BDNF polymorphism Val66Met in patients with amnestic mild cognitive impairment (A-MCI) or Alzheimer disease (AD). One hundred and seventy-six outpatients with AD (n = 129) or A-MCI (n = 47) were selected and their plasma BDNF concentrations measured. Next, we investigated the correlation between the plasma BDNF level and the Behavioral Pathology in Alzheimer Disease (Behave-AD) subscale scores, which reflect neuropsychiatric symptoms. We also compared the plasma BDNF level and the Behave-AD subscale scores among the BDNF Val66Met genotypic groups. Among the seven Behave-AD subscale scores, aggressiveness was positively correlated with the plasma BDNF level (ρ = 0.237, P < 0.005), but did not differ significantly among the three BDNF Val66Met genotypic groups. The Behave-AD total and other subscale scores did not differ significantly among the BDNF Val66Met genotypic groups and were not associated with the plasma BDNF level. Moreover, the plasma BDNF level did not differ significantly among the three BDNF Val66Met genotypic groups or between patients with A-MCI and those with AD. The plasma BDNF level was robustly correlated with aggressiveness, implying that the plasma BDNF level might be useful as a behavioral state marker in patients with AD or A-MCI.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Akatsu H, Yamagata HD, Kawamata J, Kamino K, Takeda M, Yamamoto T, Miki T, Tooyama I, Shimohama S, Kosaka K (2006) Variations in the BDNF gene in autopsy-confirmed Alzheimer’s disease and dementia with Lewy bodies in Japan. Dement Geriatr Cogn Disord 22(3):216–222

    Article  PubMed  CAS  Google Scholar 

  • Angelucci F, Spalletta G, di Iulio F, Ciaramella A, Salani F, Colantoni L, Varsi AE, Gianni W, Sancesario G, Caltagirone C, Bossù P (2010) Alzheimer’s disease (AD) and mild cognitive impairment (MCI) patients are characterized by increased BDNF serum levels. Curr Alzheimer Res 7(1):15–20

    Article  PubMed  CAS  Google Scholar 

  • Borroni B, Archetti S, Costanzi C, Grassi M, Ferrari M, Radeghieri A, Caimi L, Caltagirone C, Di Luca M, Padovani A, ITINAD Working Group (2009) Role of BDNF Val66Met functional polymorphism in Alzheimer’s disease-related depression. Neurobiol Aging 30(9):1406–1412

    Article  PubMed  CAS  Google Scholar 

  • Bruen PD, McGeown WJ, Shanks MF, Venneri A (2008) Neuroanatomical correlates of neuropsychiatric symptoms in Alzheimer’s disease. Brain 131(Pt9):2455–2463. doi:10.1093/brain/awn151

    Article  PubMed  Google Scholar 

  • Brunoni AR, Lopes M, Fregni F (2008) A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. Int J Neuropsychopharmacol 11(8):1169–1180. doi:10.1017/S1461145708009309

    Article  PubMed  CAS  Google Scholar 

  • Chen ZY, Patel PD, Sant G, Meng CX, Teng KK, Hempstead BL, Lee FS (2004) Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons. J Neurosci 24(18):4401–4411

    Article  PubMed  CAS  Google Scholar 

  • Christensen R, Marcussen AB, Wörtwein G, Knudsen GM, Aznar S (2008) Abeta (1-42) injection causes memory impairment, lowered cortical and serum BDNF levels, and decreased hippocampal 5-HT(2A) levels. Exp Neurol 210(1):164–171

    Article  PubMed  CAS  Google Scholar 

  • Cross AJ, Crow TJ, Ferrier IN, Johnson JA (1986) The selectivity of the reduction of serotonin S2 receptors in Alzheimer-type dementia. Neurobiol Aging 7(1):3–7

    Article  PubMed  CAS  Google Scholar 

  • Diniz BS, Teixeira AL (2011) Brain-derived neurotrophic factor and Alzheimer’s disease: physiopathology and beyond. Neuromolecular Med. 13(4):217–222. doi:10.1007/s12017-011-8154-x

    Article  PubMed  CAS  Google Scholar 

  • Dubois B, Slachevsky A, Litvan I, Pillon B (2000) The FAB: a frontal assessment battery at bedside. Neurology 55(11):1621–1626

    Article  PubMed  CAS  Google Scholar 

  • Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A, Zaitsev E, Gold B, Goldman D, Dean M, Lu B, Weinberger DR (2003) The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112(2):257–269

    Article  PubMed  CAS  Google Scholar 

  • Folstein MF, Folstein SE, McHugh PR (1975) “Mini-Mental State”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3):189–198

    Article  PubMed  CAS  Google Scholar 

  • Forlenza OV, Diniz BS, Teixeira AL, Ojopi EB, Talib LL, Mendonça VA, Izzo G, Gattaz WF (2010) Effect of brain-derived neurotrophic factor Val66Met polymorphism and serum levels on the progression of mild cognitive impairment. World J Biol Psychiatry 11(6):774–780. doi:10.3109/15622971003797241

    Article  PubMed  Google Scholar 

  • Fujimura H, Altar CA, Chen R, Nakamura T, Nakahashi T, Kambayashi J, Sun B, Tandon NN (2002) Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation. Thromb Haemost 87(4):728–734

    PubMed  CAS  Google Scholar 

  • Gunstad J, Benitez A, Smith J, Glickman E, Spitznagel MB, Alexander T, Juvancic-Heltzel J, Murray L (2008) Serum brain-derived neurotrophic factor is associated with cognitive function in healthy older adults. J Geriatr Psychiatry Neurol 21(3):166–170. doi:10.1177/0891988708316860

    Article  PubMed  Google Scholar 

  • Huang R, Huang J, Cathcart H, Smith S, Poduslo SE (2007) Genetic variants in brain-derived neurotrophic factor associated with Alzheimer’s disease. J Med Genet 44(2):e66

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  • Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL (1982) A new clinical scale for the staging of dementia. Br J Psychiatry 140:566–572

    Article  PubMed  CAS  Google Scholar 

  • Iga J, Ueno S, Yamauchi K, Numata S, Tayoshi-Shibuya S, Kinouchi S, Nakataki M, Song H, Hokoishi K, Tanabe H, Sano A, Ohmori T (2007) The Val66Met polymorphism of the brain-derived neurotrophic factor gene is associated with psychotic feature and suicidal behavior in Japanese major depressive patients. Am J Med Genet B Neuropsychiatr Genet 144B:1003–1006

    Article  PubMed  Google Scholar 

  • Ito W, Chehab M, Thakur S, Li J, Morozov A (2011) BDNF-restricted knockout mice as an animal model for aggression. Genes Brain Behav 10(3):365–374. doi:10.1111/j.1601-183X.2010.00676.x

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  • Klein AB, Williamson R, Santini MA, Clemmensen C, Ettrup A, Rios M, Knudsen GM, Aznar S (2011) Blood BDNF concentrations reflect brain-tissue BDNF levels across species. Int J Neuropsychopharmacol 14(3):347–353. doi:10.1017/S1461145710000738

    Article  PubMed  CAS  Google Scholar 

  • Kobayashi N, Nagata T, Shinagawa S, Oka N, Shimada K, Shimizu A, Tatebayashi Y, Yamada H, Nakayama K, Kondo K (2013) Increase in the IgG avidity index due to herpes simplex virus type 1 reactivation and its relationship with cognitive function in amnestic mild cognitive impairment and Alzheimer’s disease. Biochem Biophys Res Commun 430(3):907–911. doi:10.1016/j.bbrc.2012.12.054

    Article  PubMed  CAS  Google Scholar 

  • Lanctôt KL, Herrmann N, Eryavec G, van Reekum R, Reed K, Naranjo CA (2002) Central serotonergic activity is related to the aggressive behaviors of Alzheimer’s disease. Neuropsychopharmacology 27(4):646–654

    PubMed  Google Scholar 

  • Lang UE, Günther L, Scheuch K, Klein J, Eckhart S, Hellweg R, Danker-Hopfe H, Oehler J (2009) Higher BDNF concentrations in the hippocampus and cortex of an aggressive mouse strain. Behav Brain Res 197(1):246–249. doi:10.1016/j.bbr.2008.08.025

    Article  PubMed  CAS  Google Scholar 

  • Laske C, Stransky E, Leyhe T, Eschweiler GW, Wittorf A, Richartz E, Bartels M, Buchkremer G, Schott K (2006) Stage-dependent BDNF serum concentrations in Alzheimer’s disease. J Neural Transm. 113(9):1217–1224

    Article  PubMed  CAS  Google Scholar 

  • Lee BC, Choi IG, Kim YK, Ham BJ, Yang BH, Roh S, Choi J, Lee JS, Oh DY, Chai YG (2009) Relation between plasma brain-derived neurotrophic factors and nerve growth factor in the male patients with alcohol dependence. Alcohol 43(4):265–269

    Article  PubMed  CAS  Google Scholar 

  • Lyons WE, Mamounas LA, Ricaurte GA, Coppola V, Reid SW, Bora SH, Wihler C, Koliatsos VE, Tessarollo L (1999) Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. Proc Natl Acad Sci USA 96(26):15239–15244

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  • Matsumoto N, Ikeda M, Fukuhara R, Shinagawa S, Ishikawa T, Mori T, Toyota Y, Matsumoto T, Adachi H, Hirono N, Tanabe H (2007) Caregiver burden associated with behavioral and psychological symptoms of dementia in elderly people in the local community. Dement Geriatr Cogn Disord 23(4):219–224

    Article  PubMed  Google Scholar 

  • Matsushita S, Arai H, Matsui T, Yuzuriha T, Urakami K, Masaki T, Higuchi S (2005) Brain-derived neurotrophic factor gene polymorphisms and Alzheimer’s disease. J Neural Transm 112(5):703–711

    Article  PubMed  CAS  Google Scholar 

  • McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 34(7):939–944

    Article  PubMed  CAS  Google Scholar 

  • Murman DL, Chen Q, Powell MC, Kuo SB, Bradley CJ, Colenda CC (2002) The incremental direct costs associated with behavioral symptoms in AD. Neurology 59(11):1721–1729

    Article  PubMed  CAS  Google Scholar 

  • Nagahara AH, Merrill DA, Coppola G, Tsukada S, Schroeder BE, Shaked GM, Wang L, Blesch A, Kim A, Conner JM, Rockenstein E, Chao MV, Koo EH, Geschwind D, Masliah E, Chiba AA, Tuszynski MH (2009) Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer’s disease. Nat Med 15(3):331–337. doi:10.1038/nm.1912

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  • Nagata T, Shinagawa S, Ochiai Y, Kada H, Kasahara H, Nukariya K, Nakayama K (2010) Relationship of frontal lobe dysfunction and aberrant motor behaviors in patients with Alzheimer’s disease. Int Psychogeriatr 22(3):463–469. doi:10.1017/S1041610209991323

    Article  PubMed  Google Scholar 

  • Nagata T, Shinagawa S, Nukariya K, Yamada H, Nakayama K (2012) Association between BDNF polymorphism (Val66Met) and executive function in patients with amnestic mild cognitive impairment or mild Alzheimer disease. Dement Geriatr Cogn Disord 33(4):266–272. doi:10.1159/000339358

    Article  PubMed  CAS  Google Scholar 

  • O’Bryant SE, Hobson V, Hall JR, Waring SC, Chan W, Massman P, Lacritz L, Cullum CM, Diaz-Arrastia R, Texas Alzheimer’s Research Consortium (2009) Brain-derived neurotrophic factor levels in Alzheimer’s disease. J Alzheimers Dis. 17(2):337–341. doi:10.3233/JAD-2009-1051

    PubMed Central  PubMed  Google Scholar 

  • O’Bryant SE, Hobson VL, Hall JR, Barber RC, Zhang S, Johnson L, Diaz-Arrastia R, Texas Alzheimer’s Research Consortium (2011) Serum brain-derived neurotrophic factor levels are specifically associated with memory performance among Alzheimer’s disease cases. Dement Geriatr Cogn Disord 31(1):31–36. doi:10.1159/000321980

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  • Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, Ritchie K, Rossor M, Thal L, Winbland B (2001) Current concepts in mild cognitive impairment. Arch Neurol 58(12):1985–1992

    Google Scholar 

  • Piccinni A, Marazziti D, Catena M, Domenici L, Del Debbio A, Bianchi C, Mannari C, Martini C, Da Pozzo E, Schiavi E, Mariotti A, Roncaglia I, Palla A, Consoli G, Giovannini L, Massimetti G, Dell’Osso L (2008) Plasma and serum brain-derived neurotrophic factor (BDNF) in depressed patients during 1 year of antidepressant treatments. J Affect Disord 105(1–3):279–283

    Article  PubMed  CAS  Google Scholar 

  • Reisberg B, Borenstein J, Salob SP, Ferris SH, Franssen E, Georgotas A (1987) Behavioral symptoms in Alzheimer’s disease: phenomenology and treatment. J Clin Psychiatry 48(Suppl):9–15

    PubMed  Google Scholar 

  • Rosenberg PB, Mielke MM, Appleby BS, Oh ES, Geda YE, Lyketsos CG (2013) The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer disease. Am J Geriatr Psychiatry 21(7):685–695. doi:10.1016/j.jagp.2013.01.006

    Article  PubMed  Google Scholar 

  • Schroeter ML, Stein T, Maslowski N, Neumann J (2009) Neural correlates of Alzheimer’s disease and mild cognitive impairment: a systematic and quantitative meta-analysis involving 1351 patients. Neuroimage 47(4):1196–1206. doi:10.1016/j.neuroimage.2009.05.037

    Article  PubMed Central  PubMed  Google Scholar 

  • Sen S, Duman R, Sanacora G (2008) Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol Psychiatry 64(6):527–532. doi:10.1016/j.biopsych.2008.05.005

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  • Shaw LM, Vanderstichele H, Knapik-Czajka M, Clark CM, Aisen PS, Petersen RC, Blennow K, Soares H, Simon A, Lewczuk P, Dean R, Siemers E, Potter W, Lee VM, Trojanowski JQ (2009) Alzheimer’s disease neuroimaging initiative. Cerebrospinal fluid biomarker signature in Alzheimer’s disease neuroimaging initiative subjects. Ann Neurol 65(4):403–413. doi:10.1002/ana.21610

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  • Shibata N, Ohnuma T, Kuerban B, Komatsu M, Arai H (2011) Genetic association between ghrelin polymorphisms and Alzheimer’s disease in a Japanese population. Dement Geriatr Cogn Disord 32(3):178–181. doi:10.1159/000333075

    Article  PubMed  CAS  Google Scholar 

  • Shin SJ, Yoon HE, Chung S, Kim YG, Kim DJ (2012) Plasma brain-derived neurotrophic factor in hemodialysis patients. Int J Med Sci. 9(9):772–777. doi:10.7150/ijms.5063

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  • Teng E, Lu PH, Cummings JL (2007) Neuropsychiatric symptoms are associated with progression from mild cognitive impairment to Alzheimer’s disease. Dement Geriatr Cogn Disord 24(4):253–259

    Article  PubMed  Google Scholar 

  • Terracciano A, Piras MG, Lobina M, Mulas A, Meirelles O, Sutin AR, Chan W, Sanna S, Uda M, Crisponi L, Schlessinger D (2011) Genetics of serum BDNF: Meta-analysis of the Val66Met and genome-wide association study. World J Biol Psychiatry. doi:10.3109/15622975.2011.616533

  • Vaidya VA, Marek GJ, Aghajanian GK, Duman RS (1997) 5-HT2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex. J Neurosci 17(8):2785–2795

    PubMed  CAS  Google Scholar 

  • Vermeiren Y, Le Bastard N, Van Hemelrijck A, Drinkenburg WH, Engelborghs S, De Deyn PP (2012) Behavioral correlates of cerebrospinal fluid amino acid and biogenic amine neurotransmitter alterations in dementia. Alzheimer Dement. doi:10.1016/j.jalz.2012.06.010

    Google Scholar 

  • Voineskos AN, Lerch JP, Felsky D, Shaikh S, Rajji TK, Miranda D, Lobaugh NJ, Mulsant BH, Pollock BG, Kennedy JL (2011) The brain-derived neurotrophic factor Val66Met polymorphism and prediction of neural risk for Alzheimer disease. Arch Gen Psychiatry 68(2):198–206. doi:10.1001/archgenpsychiatry.2010.194

    Article  PubMed  Google Scholar 

  • Yu H, Zhang Z, Shi Y, Bai F, Xie C, Qian Y, Yuan Y, Deng L (2008) Association study of the decreased serum BDNF concentrations in amnestic mild cognitive impairment and the Val66Met polymorphism in Chinese Han. J Clin Psychiatry 69(7):1104–1111

    Article  PubMed  CAS  Google Scholar 

  • Zarros ACh, Kalopita KS, Tsakiris ST (2005) Serotoninergic impairment and aggressive behavior in Alzheimer’s disease. Acta Neurobiol Exp (Wars) 65(3):277–286

    Google Scholar 

  • Zhang XY, da Chen C, Xiu MH, Haile CN, Luo X, Xu K, Zhang HP, Zuo L, Zhang Z, Zhang X, Kosten TA, Kosten TR (2012) Cognitive and serum BDNF correlates of BDNF Val66Met gene polymorphism in patients with schizophrenia and normal controls. Hum Genet 131(7):1187–1195. doi:10.1007/s00439-012-1150-x

    Article  PubMed Central  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, The Jikei University School of Medicine, 3-25-8 Nishishimbashi, Minato-ku, Tokyo, 105-8471, Japan

    Tomoyuki Nagata, Nobuyuki Kobayashi, Shunichiro Shinagawa & Kazuhiko Nakayama

  2. Department of Virology, The Jikei University School of Medicine, 3-25-8 Nishishimbashi, Minato-ku, Tokyo, 105-8471, Japan

    Nobuyuki Kobayashi & Kazuhiro Kondo

  3. Division of Molecular Genetics, Institute of DNA Medicine, The Jikei University School of Medicine, 3-25-8 Nishishimbashi, Minato-ku, Tokyo, 105-8471, Japan

    Tomoyuki Nagata & Hisashi Yamada

Authors
  1. Tomoyuki Nagata
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nobuyuki Kobayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shunichiro Shinagawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hisashi Yamada
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kazuhiro Kondo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kazuhiko Nakayama
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tomoyuki Nagata.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nagata, T., Kobayashi, N., Shinagawa, S. et al. Plasma BDNF levels are correlated with aggressiveness in patients with amnestic mild cognitive impairment or Alzheimer disease. J Neural Transm 121, 433–441 (2014). https://doi.org/10.1007/s00702-013-1121-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00702-013-1121-y

Keywords

Search

Navigation